Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Ativan

Generic name: Lorazepam

FDA application holder: Hikma

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Ativan?
Ativan is a brand name of Lorazepam, a prescription medicine. The FDA NDC Directory lists 7 Ativan products in 5 strengths and forms.
Who makes Ativan?
Hikma holds the FDA application for Ativan (NDA017794, approved September 30, 1977). 1 other company (repackagers or distributors) also list Ativan products.
Is there a generic or store brand of Ativan?
Yes. The FDA NDC Directory lists 127 other products with the same active ingredients, strength and form as a Ativan product, 117 of them generic. Ask your pharmacist whether one is right for you.
Has Ativan been recalled?
FDA enforcement reports list 1 recall of Ativan products; the newest started July 11, 2022. A recall usually concerns specific lots, not every product.

What Ativan is

Each Ativan product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Lorazepam · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
lorazepam 0.5 mg
tablet (oral)
Ativan 40 products, 25 companies DailyMed
lorazepam 1 mg
tablet (oral)
Ativan 45 products, 25 companies DailyMed
lorazepam 2 mg
tablet (oral)
Ativan 30 products, 19 companies DailyMed
lorazepam 2 mg/mL
injection (intramuscular, intravenous)
Ativan 8 products, 4 companies —
lorazepam 4 mg/mL
injection (intramuscular, intravenous)
Ativan 4 products, 1 company —

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Lorazepam →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Ativan products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA017794BauschSeptember 30, 19773
NDA018140HikmaJuly 25, 19804

Companies that list Ativan

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Ativan products.

Recalls

From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.

  1. July 11, 2022 · Class II · Terminated · D-1308-2022

    Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.

    Ativan Injection (lorazepam injection, USP), 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured by West-Ward Eatontown, NJ 07724, Carton NDC# 0641-6001-25, Vial NDC# 0641-6001-01 — Hikma Pharmaceuticals USA Inc.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers